Full Press Release Details
LOS ANGELES, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises TransMedics Group, Inc. (“TransMedics” or “the Company”) (NASDAQ: TMDX) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. TransMedics investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: info@portnoylaw.com, to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
The investigation is examining whether the Company made false and/or misleading statements and/or failed to disclose critical information to investors. TransMedics is the subject of a report released by Scorpion Capital on January 10, 2025. The report alleges that, in its 20 years of shorting stocks, TransMedics represents the most extreme and grotesque case of healthcare fraud encountered. It claims that the fraud is not only significant in scale but also exploits the most vulnerable patients—those terminally ill and in desperate need of an organ. According to the report, the "fortunate" patients who receive a diseased or damaged organ rejected by reputable surgeons and centers are unaware of the hidden, unethical incentives that led to the organ being provided to them.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bars
Attorney Advertising